Patents: Pfizer and Others v Ranbaxy Labs and others

The latest round in the Pfizer v Ranbaxy struggle took place in front of District Judge Farnan of the US District Court for Delaware on Friday and as most people who have been following this epic on at least three continents will already know it went to Pfizer. A transcript of the judgment can be downloaded courtesy of the court website.

According to The Hindu business news Ranbaxy intends to appeal which is not surprising given that its share price is some way off its best. The Hindu also gives a link to the decision in Norway and I've mentioned lipitor litigation in Ireland and the USA as well as here in this blog.

Comments

Popular posts from this blog

Were we to go - what would Brexit mean for IP?

The Draft Patents (European Patent with Unitary Effect and Unified Patent Court) Order 2016

Supreme Court upholds Court of Appeal in Trunki